<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
    xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">

    <url>
        <loc>https://www.transformmyeloma.com/minimal-residual-disease/importance-of-mrd.html</loc>
        <video:video>
            <video:thumbnail_loc>
                https://i.vimeocdn.com/video/1865497947-b19f00260f180c8c68bad78da92f943ee5ddbd4d9fcc39ef74e6de6df88f404c-d?</video:thumbnail_loc>
            <video:title>Watch a video exploring MRD negativity as a goal of therapy of multiple
                myeloma</video:title>
            <video:description>Dr Rafael Alonso discusses the relevance of MRD- as a measure of
                depth of response, and its importance as a treatment goal, particularly in frontline
                therapy. He also explores how the role of MRD- may evolve in the future, both as an
                endpoint and a potential tool to guide decisions in clinical practice.</video:description>
            <video:content_loc>https://player.vimeo.com/video/954577035</video:content_loc>
            <video:duration>447</video:duration>
        </video:video>
    </url>
    <url>
        <loc>https://www.transformmyeloma.com/minimal-residual-disease/importance-of-mrd.html</loc>
        <video:video>
            <video:thumbnail_loc>
                https://i.vimeocdn.com/video/1901340572-fff308631ac6cf0cbb056b00ec7a7ea1e8e0abeafa0106539156d2210fe493a8-d?</video:thumbnail_loc>
            <video:title>Jim gives his perspective on MRD negativity and living with multiple
                myeloma</video:title>
            <video:content_loc>https://player.vimeo.com/video/985802176</video:content_loc>
            <video:duration>160</video:duration>
        </video:video>
    </url>
</urlset>